Chronic rhinossinusitis with nasal polyps (CRSwNP) biopsy – when, how and why?

Authors

DOI:

https://doi.org/10.34631/sporl.3093

Keywords:

Nasal polyps, neutrophils, eosinophils, rhinossinusitis

Abstract

Objective: To assess the impact of nasal tissue neutrophilia on dupilumab response in severe, uncontrolled CRSwNP.

Methodology: Retrospective study, 23 CRSwNP patients on dupilumab assessed at baseline and 6 months. Systemic IgE and eosinophilia, tissue eosinophilia and neutrophilia were recorded. Evaluation of Sino-nasal Outcome Test (SNOT-22), Visual Analogue Scale (VAS) total symptoms, Nasal Polyp Score (SPN), Barcelona Smell Test 24 (BAST-24), Nasal Congestion Score (SCN), and Smell Loss Score (SPO).

Results: Mean tissue neutrophil count was 2±2.3, ranging from 0 to 8 per high-power field. Correlation was observed between tissue neutrophilia and SPO variation (r= 0.464, p = 0.034) and direct correlations between tecidual eosinophilia and neutrophilia (r=0.595, p=0.004) and between tecidual neutrophilia and sistemic IgE (r=0.548, p=0.010).

Conclusion: Higher neutrophil levels appear linked to resistance to dupilumab, with less improvement in SPO. Sample size limits data reliability, warranting further studies with larger samples.

Downloads

Download data is not yet available.

References

Fokkens WJ, Lund VJ, Hopkins C, Hellings PW, Kern R, Reitsma S. et al. European Position Paper on Rhinosinusitis and Nasal Polyps 2020. Rhinology. 2020 Feb 20;58(Suppl S29):1-464. doi: 10.4193/Rhin20.600.

Xie X, Wang P, Jin M, Wang Y, Qi L, Wu C. et al. IL-1β-induced epithelial cell and fibroblast transdifferentiation promotes neutrophil recruitment in chronic rhinosinusitis with nasal polyps. Nat Commun. 2024 Oct 22;15(1):9101. doi: 10.1038/s41467-024-53307-0.

Lin YT, Tsai MH, Su YY, Huang SC. Comparison of cytokine expression and disease severity between plasma cell-dominant and eosinophil-dominant patients in chronic rhinosinusitis with nasal polyps. Allergy Asthma Clin Immunol. 2024 May 21;20(1):34. doi: 10.1186/s13223-024-00896-6.

Habenbacher M, Moser U, Abaira A, Kiss P, Holzmeister C, Pock J. et al. Investigation of blood count-based inflammatory biomarkers as predictors of response to dupilumab treatment in patients with chronic rhinosinusitis with nasal polyps. Pharmaceutics. 2024 Oct 25;16(11):1370. doi: 10.3390/pharmaceutics16111370.

Delemarre T, Holtappels G, De Ruyck N, Zhang N, Nauwynck H, Bachert C. et al. A substantial neutrophilic inflammation as regular part of severe type 2 chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol. 2021 Jan;147(1):179-188.e2. doi: 10.1016/j.jaci.2020.08.036.

Delemarre T, Bachert C. Neutrophilic inflammation in chronic rhinosinusitis. Curr Opin Allergy Clin Immunol. 2023 Feb 1;23(1):14-21. doi: 10.1097/ACI.0000000000000868.

Lane AP, Turner J, May L, Reed R. A genetic model of chronic rhinosinusitis-associated olfactory inflammation reveals reversible functional impairment and dramatic neuroepithelial reorganization. J Neurosci. 2010 Feb 10;30(6):2324-9. doi: 10.1523/JNEUROSCI.4507-09.2010.

Published

2025-12-12

How to Cite

Bulha, M., V. Dias, D., Padrão, M., Cales, S., Eloi, I., Augusto, S., & Azevedo, L. (2025). Chronic rhinossinusitis with nasal polyps (CRSwNP) biopsy – when, how and why?. Portuguese Journal of Otorhinolaryngology and Head and Neck Surgery, 63(4), 451–458. https://doi.org/10.34631/sporl.3093